ABRACL Human Pre-designed siRNA Set A contains three designed siRNAs for ABRACL gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ABRAXAS1 Human Pre-designed siRNA Set A contains three designed siRNAs for ABRAXAS1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ABT-080 is an orally active inhibitor of leukotriene biosynthesis. ABT-080 simultaneously blocks the leukotriene pathways leading to the synthesis of LTB4 and LTC4, but does not inhibit PGH2 biosynthesis. ABT-080 can block bronchoconstriction and be used in the research of asthma and related inflammations[1]

ABT1 Human Pre-designed siRNA Set A contains three designed siRNAs for ABT1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ABTB1 Human Pre-designed siRNA Set A contains three designed siRNAs for ABTB1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ABTB2 Human Pre-designed siRNA Set A contains three designed siRNAs for ABTB2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Abz-Gly-Leu-Lys-Arg-Gly-Gly-3-(NO2)Tyr acetate is the acetate salt form of Abz-Gly-Leu-Lys-Arg-Gly-Gly-3-(NO2)Tyr. Abz-Gly-Leu-Lys-Arg-Gly-Gly-3-(NO2)Tyr acetate is the substrate for WNV NS2B NS3 protease, which is utilized for the development of WNV protease substrate peptide selective inhibitor[1].

Abz-Gly-Leu-Lys-Arg-Gly-Gly-3-(NO2)Tyr acetate is the acetate salt form of Abz-Gly-Leu-Lys-Arg-Gly-Gly-3-(NO2)Tyr. Abz-Gly-Leu-Lys-Arg-Gly-Gly-3-(NO2)Tyr acetate is the substrate for WNV NS2B NS3 protease, which is utilized for the development of WNV protease substrate peptide selective inhibitor[1].

Abz-Gly-Leu-Lys-Arg-Gly-Gly-3-(NO2)Tyr acetate is the acetate salt form of Abz-Gly-Leu-Lys-Arg-Gly-Gly-3-(NO2)Tyr. Abz-Gly-Leu-Lys-Arg-Gly-Gly-3-(NO2)Tyr acetate is the substrate for WNV NS2B NS3 protease, which is utilized for the development of WNV protease substrate peptide selective inhibitor[1].

Abz-Nle-Lys-Arg-Arg-Ser-3-(NO2)Tyr acetate is a DEN protease substrate, which can be used in research related to dengue virus (drug development)[1].

Abz-Nle-Lys-Arg-Arg-Ser-3-(NO2)Tyr acetate is a DEN protease substrate, which can be used in research related to dengue virus (drug development)[1].

Abz-Nle-Lys-Arg-Arg-Ser-3-(NO2)Tyr acetate is a DEN protease substrate, which can be used in research related to dengue virus (drug development)[1].

Ac-{Cpg}-Thr-Ala-{Ala(CO)}-Asp-{Cpg}-NH2 (compound 40) is a potent Plasmodium subtilisin-like protease 1 (SUB1) inhibitor. SUB1-IN-1 shows IC50 values of 12 nM and 10 nM against P. vivax and P. falciparum SUB1 (Pv- and PfSUB1), respectively[1].

AC-263093 (AC-093) functionally activates NPFFR2 and blocks activation of NPFFR1 with pKis of 6.9 and 7.0, respectively. AC-263093 has the potential for reversing opiate tolerance research[1]. .

AC-263093 (AC-093) functionally activates NPFFR2 and blocks activation of NPFFR1 with pKis of 6.9 and 7.0, respectively. AC-263093 has the potential for reversing opiate tolerance research[1]. .

AC-263093 (AC-093) functionally activates NPFFR2 and blocks activation of NPFFR1 with pKis of 6.9 and 7.0, respectively. AC-263093 has the potential for reversing opiate tolerance research[1]. .

AC-263093 (AC-093) functionally activates NPFFR2 and blocks activation of NPFFR1 with pKis of 6.9 and 7.0, respectively. AC-263093 has the potential for reversing opiate tolerance research[1]. .

AC-263093 (AC-093) functionally activates NPFFR2 and blocks activation of NPFFR1 with pKis of 6.9 and 7.0, respectively. AC-263093 has the potential for reversing opiate tolerance research[1]. .

AC-430 hydrobromide (example 1) is a potent JAK2 inhibitor. AC-430 hydrobromide can be used for the research of myeloproliferative disorders and cancer[1].

Ac-DMQD-CHO is a selective inhibitor for caspase 3, with IC50 of 39 nM. Ac-DMQD-CHO reduces apoptosis, and exhibits neuroprotective efficacy[1].

Ac-IHIHIYI-NH2 is a fibrous heptapeptide that forms fibril-like structures with even higher esterase activity[1].

Ac-IHIHIYI-NH2 TFA is an amyloid self-assembling peptide variant that can be used as a bioactive nanomaterial with esterase activity[1].

Ac-LEHD-CHO is an inhibitor for caspase 8/9. Ac-LEHD-CHO prevents GalN/TNF-α-induced hepatotoxicity and hepatocyte apoptosis[1].

Ac-Phe-Thiaphe-OH is a modified peptide, which is utilized as substrate for carboxypeptidase A (CPA)[1].

Ac-PSMA-trillium is a PSMA targeting compound, consisting of a PSMA targeting molecule (PSMA binder), a Macropa chelating molecule, and a group that regulates pharmacokinetics (PK modifier). Ac-PSMA-trillium is a non-radioactive form of Actinium-225-PSMA-Trillium (BAY 3563254) with improved PSMA targeting and pharmacokinetic properties. PSMA-trillium can bind Ac through the Macropa chelating molecule, or the radioactive isotope […]

Ac-QPKK(Ac)-AMC is a fluorogenic substrate for sirtuin through sirtuin deacetylation[1].

Ac-VAD-AFC is a fluorescent substrate for caspases and can be used to test the activity of caspases[1][2].

Ac-VAD-CMK is a pan inhibitor for caspase 1[1].

Ac-VEID-pNA is an artificially synthesized peptide. Ac-VEID-pNA is utilized as substrate for caspase 6, that cleaves the lamin A at the cleavage site of VEID[1].

Ac-WEHD-pNA is a colorimetric substrate for caspase 1, 4, 5 and 14, which is utilized to measure the caspase activity[1].

Ac-WVAD-AMC is a fluorogenic substrate for caspase 1[1].

Ac-YVAD-AMC is an inhibitor for caspase. Ac-YVAD-AMC inhibits bacteria-induced cell death of hypersensitive response (HR) cells[1].

Ac-YVAD-FMK is an inhibitor for caspase 1-like protease[1].

Ac5GalNTGc epimer is an analogue of hexosamine and the racemate of Ac5GalNTGc (HY-160109). Ac5GalNTGc inhibits mucin-type O-linked glycosylation biosynthesis[1].

Ac5GalNTGc epimer is an analogue of hexosamine and the racemate of Ac5GalNTGc (HY-160109). Ac5GalNTGc inhibits mucin-type O-linked glycosylation biosynthesis[1].

ACAA1 Human Pre-designed siRNA Set A contains three designed siRNAs for ACAA1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ACAA2 Human Pre-designed siRNA Set A contains three designed siRNAs for ACAA2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ACACA Human Pre-designed siRNA Set A contains three designed siRNAs for ACACA gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Acaca Mouse Pre-designed siRNA Set A contains three designed siRNAs for Acaca gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Acaca Rat Pre-designed siRNA Set A contains three designed siRNAs for Acaca gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

ACACB Human Pre-designed siRNA Set A contains three designed siRNAs for ACACB gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ACAD10 Human Pre-designed siRNA Set A contains three designed siRNAs for ACAD10 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ACAD11 Human Pre-designed siRNA Set A contains three designed siRNAs for ACAD11 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ACAD8 Human Pre-designed siRNA Set A contains three designed siRNAs for ACAD8 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ACAD9 Human Pre-designed siRNA Set A contains three designed siRNAs for ACAD9 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ACADL Human Pre-designed siRNA Set A contains three designed siRNAs for ACADL gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ACADM Human Pre-designed siRNA Set A contains three designed siRNAs for ACADM gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ACADS Human Pre-designed siRNA Set A contains three designed siRNAs for ACADS gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.